IκB-kinase/nuclear factor-κB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation

Critical Care Medicine

Volumn 35, Issue 5, 2007, Pages 1332-1340

  Chen, Lee Wei ^a   Chen, Pei Hsuan ^a   Chang, Wei Jung ^a   Wang, Jyh Seng ^a   Karin, Michael ^b   Hsu, Ching Mei ^c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Burn; c Jun NH2 terminal; I B kinase; Nuclear factor B; SB203580; SP600125

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; FLICE INHIBITORY PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45BETA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; PROTEIN BCL XL; PROTEIN BFL 1; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; BCL2L1 PROTEIN, MOUSE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL X; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SURFACE; BURN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL STUDY; GROWTH DISORDER; INTESTINE FUNCTION; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; THERMAL INJURY; ANIMAL; APOPTOSIS; DISEASE MODEL; DRUG ANTAGONISM; ENZYME ACTIVATION; EPITHELIUM CELL; GENETICS; INJURY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PERMEABILITY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTHRACENES; APOPTOSIS; BCL-X PROTEIN; BURNS; CASPASE 3; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; EPITHELIAL CELLS; I-KAPPA B KINASE; IMIDAZOLES; INTESTINAL MUCOSA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, KNOCKOUT; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERMEABILITY; PHOSPHORYLATION; PYRIDINES; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 34247373897     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000261891.30360.F0     Document Type: Article

References (30)

1. Rothwarf DM, Karin M: The NF-kappa B activation pathway: A paradigm in information transfer from membrane to nucleus. Sci STKE 1999; 1999:RE1
2. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18:621-663
3. Spies M, Chappell VL, Dasu MR, et al: Role of TNF-alpha in gut mucosal changes after severe burn. Am J Physiol Gastrointest Liver Physiol 2002; 283:G703-G708
4. Li Q, Van Antwerp D, Mercurio F, et al: Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 1999; 284:321-325
5. Egan LJ, Eckmann L, Greten FR, et al: IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Nat Acad Sci U S A 2004; 101:2452-2457
6. Baud V, Karin M: Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11:372-377
7. Hu M, Du Q, Vancurova I, et al: Proapoptotic effect of curcumin on human neutrophils: Activation of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2005; 33:2571-2578
8. Zhang X, Bedard EL, Potter R, et al: Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol 2002; 283:L815-L829
9. Sanlorenzo L, Zhao B, Spight D, et al: Heat shock inhibition of lipopolysaccharide-mediated tumor necrosis factor expression is associated with nuclear induction of MKP-1 and inhibition of mitogen-activated protein kinase activation. Crit Care Med 2004; 32:2284-2292
10. Hommes DW, Peppelenbosch MP, van Deventer SJ: Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003; 52:144-151
11. Han Z, Boyle DL, Chang L, et al: c-Jun Nterminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001; 108:73-81
12. Shoup M, Weisenberger JM, Wang JL, et al: Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann Surg 1998; 228:112-122
13. Otamiri T, Sjodahl R, Tagesson C: An experimental model for studying reversible intestinal ischemia. Acta Chir Scand 1987; 153:51-56
14. Chen LW, Hsu CM, Cha MC, et al: Changes in gut mucosal nitric oxide synthase (NOS) activity after thermal injury and its relation with barrier failure. Shock 1999; 11:104-110
15. Chen LW, Egan L, Li ZW, et al: The two faces of IKK and NF-kappaB inhibition: Prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003; 9:575-581
16. Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3:221-227
17. Jones WK, Brown M, Ren X, et al: NF-kappaB as an integrator of diverse signaling pathways: The heart of myocardial signaling? Cardiovasc Toxicol 2003; 3:229-254
18. De Smaele E, Zazzeroni F, Papa S, et al: Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001; 414:308-313
19. Habelhah H, Takahashi S, Cho SG, et al: Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J 2004; 23:322-332
20. Neurath MF, Becker C, Barbulescu K: Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 1998; 43:856-860
21. Dijkstra G, Moshage H, Jansen PL: Blockade of NF-kappaB activation and donation of nitric oxide: New treatment options in inflammatory bowel disease? Scand J Gastroenterol Suppl 2002; 236:37-41
22. Jeschke MG, Low JF, Spies M, et al: Cell proliferation, apoptosis, NF-kappaB expression, enzyme, protein, and weight changes in livers of burned rats. Am J Physiol Gastrointest Liver Physiol 2001; 280:G1314-G1320
23. Jobin C, Sartor RB: The I kappa B/NF-kappa B system: A key determinant of mucosalin-flammation and protection. Am J Physiol Cell Physiol 2000; 278:C451-C462
24. Kreuz S, Siegmund D, Scheurich P, et al: NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 2001; 21:3964-3973
25. Rayet B, Fan Y, Gelinas C: Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity. Mol Cell Biol 2003; 23:1520-1533
26. Yu C, Minemoto Y, Zhang J, et al: JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 2004; 13:329-340
27. Liu J, Lin A: Role of JNK activation in apoptosis: A double-edged sword. Cell Res 2005; 15:36-42
28. Nakano H: Signaling crosstalk between NF-kappaB and JNK. Trends Immunol 2004; 25:402-405
29. Parhar K, Ray A, Steinbrecher U, et al: The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. Immunology 2003; 108:502-512
30. Park JG, Yuk Y, Rhim H, et al: Role of p38 MAPK in the regulation of apoptosis signaling induced by TNF-alpha in differentiated PC12 cells. J Biochem Mol Biol 2002; 35:267-272